DEF: Aura Biosciences Sets Date for 2025 Annual Stockholders Meeting

Aura Biosciences announces its 2025 Annual Meeting of Stockholders to be held virtually on June 17, 2025, covering director elections and auditor ratification.

Summary

• Aura Biosciences will hold its 2025 Annual Meeting of Stockholders virtually on June 17, 2025, at 9:30 a.m. Eastern Time.
• Stockholders of record as of April 21, 2025, are entitled to vote.
• The meeting will address the election of two Class I directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and any other business properly brought before the meeting.
• The Board of Directors has nominated Elisabet de los Pinos, Ph.D., and Giovanni Mariggi, Ph.D., for election as Class I directors.
• The company is following the SEC's Notice and Access rule, providing proxy materials online, with a Notice of Internet Availability mailed to stockholders on or about April 24, 2025.
• Stockholders can vote online, by phone, or by mail, with specific deadlines for each method.
• The proxy statement and the 2024 Annual Report are available online at www.ProxyVote.com/.
• The company's common stock outstanding as of April 21, 2025, was 50,268,758 shares.
• The Board of Directors recommends voting FOR the election of Elisabet de los Pinos, Ph.D. and Giovanni Mariggi, Ph.D. as Class I directors.
• The Board of Directors recommends voting FOR the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

Sentiment

Score: 7

Explanation: The document is a routine proxy statement, presenting standard corporate governance matters. The tone is neutral and factual, reflecting the necessary disclosures for an annual meeting. There are no indications of significant positive or negative developments, resulting in a moderate sentiment score.

Positives

• The virtual format of the Annual Meeting is designed to enhance stockholder access, participation, and communication.
• Stockholders have multiple options for voting: online, by phone, or by mail.
• The company provides clear instructions and support for attending and participating in the virtual Annual Meeting.
• The company is committed to good corporate governance by submitting the appointment of Ernst & Young LLP to the stockholders for ratification.

Future Outlook

The document does not contain specific forward-looking statements about the company's financial performance or business prospects beyond the procedural aspects of the annual meeting.

Management Comments

• Elisabet de los Pinos, Ph.D., Chief Executive Officer, states that the meeting notice is given by order of the Board of Directors.
• The Board of Directors believes that submitting the appointment of Ernst & Young LLP to the stockholders for ratification is good corporate governance.

Industry Context

This announcement is a standard corporate procedure for publicly traded companies, ensuring compliance with SEC regulations and providing stockholders with the opportunity to participate in key decisions.

Comparison to Industry Standards

• The virtual meeting format aligns with a growing trend among public companies to enhance accessibility and reduce costs.
• The director nomination and auditor ratification processes are standard practices for publicly traded companies.
• The fee structure and pre-approval policies for audit services are consistent with industry best practices to ensure auditor independence.

Stakeholder Impact

• Shareholders have the opportunity to vote on key decisions, influencing the company's direction.
• The outcome of the director elections and auditor ratification will impact the company's governance and financial oversight.
• Employees are indirectly affected by the decisions made at the Annual Meeting, as they contribute to the company's overall performance.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will announce preliminary voting results at the Annual Meeting.
• Final voting results will be published in a Current Report on Form 8-K filed with the SEC.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Auditor Ratification, Corporate Governance, Aura Biosciences